0001628280-22-006408.txt : 20220316 0001628280-22-006408.hdr.sgml : 20220316 20220316170922 ACCESSION NUMBER: 0001628280-22-006408 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220314 FILED AS OF DATE: 20220316 DATE AS OF CHANGE: 20220316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bartram Richard CENTRAL INDEX KEY: 0001723729 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35986 FILM NUMBER: 22745712 MAIL ADDRESS: STREET 1: C/O ESPERION THERAPEUTICS, INC. STREET 2: 3891 RANCHERO DRIVE, SUITE 150 CITY: ANN ARBOR STATE: MI ZIP: 48108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Esperion Therapeutics, Inc. CENTRAL INDEX KEY: 0001434868 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3891 RANCHERO DRIVE, SUITE 150 CITY: ANN ARBOR STATE: MI ZIP: 48108 BUSINESS PHONE: 734-887-3903 MAIL ADDRESS: STREET 1: 3891 RANCHERO DRIVE, SUITE 150 CITY: ANN ARBOR STATE: MI ZIP: 48108 FORMER COMPANY: FORMER CONFORMED NAME: HDL THERAPEUTICS INC DATE OF NAME CHANGE: 20080513 4 1 wf-form4_164746494792741.xml FORM 4 X0306 4 2022-03-14 0 0001434868 Esperion Therapeutics, Inc. ESPR 0001723729 Bartram Richard C/O ESPERION THERAPEUTICS, INC. 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 0 1 0 0 Chief Financial Officer Common Stock 2022-03-14 4 A 0 37000 0 A 82751 D Stock Option (right to buy 4.74 2032-03-14 Common Stock 159000.0 159000 D The awards will vest quarterly over four years beginning on March 15, 2022. Consists of 82,751 shares of common stock held, including 1,899 shares acquired in Esperion's Employee Stock Purchase Plan. /s/ Richard B. Bartram 2022-03-16